T

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of SFY.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SFY Intrinsic Value
Not Available
T
Base Case Scenario
Compare SFY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TOVX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Theriva Biologics Inc

Current Assets 14.7m
Cash & Short-Term Investments 12.1m
Receivables 1.9m
Other Current Assets 744k
Non-Current Assets 21.1m
PP&E 1.3m
Intangibles 19.6m
Other Non-Current Assets 128k
Current Liabilities 12.4m
Accounts Payable 607k
Accrued Liabilities 4.4m
Other Current Liabilities 7.4m
Non-Current Liabilities 12.8m
Long-Term Debt 1.6m
Other Non-Current Liabilities 11.2m
Efficiency

Free Cash Flow Analysis
Theriva Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Theriva Biologics Inc

Revenue
0 USD
Operating Expenses
-30m USD
Operating Income
-30m USD
Other Expenses
461k USD
Net Income
-29.6m USD
Fundamental Scores

SFY Profitability Score
Profitability Due Diligence

Theriva Biologics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
25/100
Profitability
Score

Theriva Biologics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

SFY Solvency Score
Solvency Due Diligence

Theriva Biologics Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
54/100
Solvency
Score

Theriva Biologics Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SFY Price Targets Summary
Theriva Biologics Inc

There are no price targets for SFY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TOVX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TOVX Insider Trading
Buy and sell transactions by insiders